Research Articles

Aiming for 90-90-90 - the importance of understanding the risk factors for HIV exposure and advanced HIV infection in migrant populations and other groups who do not report male-to-male sex.

Peach E, Lemoh C, Stoove M, Agius P, El Hayek C, Higgins N, Hellard M

Evaluation of Preexposure (PrEP) Eligibility Criteria, Using Sexually Transmissible Infections as Markers of Human Immunodeficiency Virus (HIV) Risk at Enrollment in PrEPX, a Large Australian HIV PrEP Trial.

Cornelisse VJ, Fairley CK, Stoove M, Asselin J, Chow EPF, Price B, Roth NJ, Willcox J, Tee BK, Penn M, Chang CC, Armishaw J, Forgan-Smith G, Wright EJ, PrEPX Study Team

Transformation of Australian Community Pharmacies Into Good Clinical Practice Compliant Trial Pharmacies for HIV Pre-Exposure Prophylaxis.

Lal L, Ryan K, Liu IY, Price B, Lockwood T, Aguirre I, Slobodian P, Lam A, Vassan M, Lim K, Silverii J, Tesoriero J, Phu J, Lim W, Naidoo B, Russell N, Rundle M, Sewell R, Cooper C, Hardman A, Quinn M, Mak A, Wright EJ

Assessing individual-level needle and syringe coverage parameters and the measurement of coverage in Melbourne, Australia: methods and impacts.

O'Keefe D, Scott N, Aitken C, Dietze P

“They just don’t care about us!”: Police custody experiences for young men with histories of injecting drug use

Walker S, Higgs P, Stoové M, Wilson M

https:/Performance of the Hospital-Acquired Complication (HAC) algorithm for detecting hospital-onset bloodstream infections./www.burnet.edu.au/media/snxavemi/swaziland-report.pdf

Curtis S J, Worth L J, Stuart R L, Marshall C, Johnson P DR, Attwood L O, Lee A S, Cheng A C, Stewardson A J